Corbus Pharmaceuticals Holdings (CRBP) Net Margin (2015 - 2021)

Corbus Pharmaceuticals Holdings has reported Net Margin for 7 years, with the latest figure at 14257.07% in Q3 2021.

• On a quarterly basis, Net Margin fell 1149635.0% year-over-year to 14257.07% in Q3 2021; TTM through Jun 2022 was 45961.32%, a 4271029.0% decrease from a year earlier, with the FY2021 full-year figure at 6350.09%, down 323088.0% from the prior year.
• Net Margin was 14257.07% for Q3 2021 at Corbus Pharmaceuticals Holdings, down from 12212.94% in the prior quarter.
• The five-year high for Net Margin was 7.4% in Q2 2019, with the low at 14257.07% in Q3 2021.
• Average Net Margin over 5 years is 3421.38%, with a median of 1404.73% recorded in 2018.
• The sharpest annual moves came in 2019 and 2020: Net Margin jumped 142807 bps in 2019, then plunged 1332208 bps in 2020.
• Over 5 years, Net Margin stood at 868.18% in 2017, then slipped by 4 bps to 900.03% in 2018, then decreased by 17 bps to 1050.66% in 2019, then sank by 201 bps to 3161.99% in 2020, then tumbled by 351 bps to 14257.07% in 2021.
• The last three Net Margin figures came in at 14257.07% (Q3 2021), 12212.94% (Q2 2021), and 2383.82% (Q1 2021), per Business Quant data.